Interaction of ceruloplasmin and 5-lipoxygenase

被引:0
|
作者
A. V. Sokolov
E. A. Golenkina
V. A. Kostevich
V. B. Vasilyev
G. F. Sud’ina
机构
[1] Research Institute of Experimental Medicine,Belozersky Institute of Physico
[2] Lomonosov Moscow State University,Chemical Biology
来源
Biochemistry (Moscow) | 2010年 / 75卷
关键词
protein-protein interaction; inflammation; leukotrienes; 5-lipoxygenase; ceruloplasmin;
D O I
暂无
中图分类号
学科分类号
摘要
The interaction between ceruloplasmin (CP), the multicopper oxidase of human plasma, and 5-lipoxygenase (5-LO), the key enzyme of leukotriene synthesis, is shown for the first time. By Western-blotting and mass spectrometry of tryptic fragments, it is shown that 5-LO from protein extract of human leukocytes binds with immobilized CP. Dose-dependent influence of intact CP on leukotrienes synthesis is found: CP reduced leukotrienes synthesis in leukocytes in a dose above 50 μg/ml (normal CP concentration in plasma is about 300–400 μg/ml). Proteolyzed CP and apo-form of CP is unable to inhibit activity of 5-LO. CP increased activity of 5-LO at low doses (5–10 μg/ml). On the whole, the influence of CP on phagocytosis index of leukocytes coordinates with influence on activity of 5-LO: the index increased in the range of 2–10 μg/ml CP and decreased at doses of CP above 40 μg/ml. The dual role of CP in regulation of cellular response of leukocytes is discussed.
引用
收藏
页码:1464 / 1469
页数:5
相关论文
共 50 条
  • [21] Protection of dopaminergic neurons by 5-lipoxygenase inhibitor
    Kang, Kai-Hsiang
    Liou, Horng-Hui
    Hour, Mann-Jen
    Liou, Houng-Chi
    Fu, Wen-Mei
    NEUROPHARMACOLOGY, 2013, 73 : 380 - 387
  • [22] 5-Lipoxygenase: Its involvement in gastrointestinal malignancies
    Merchant, Neha
    Bhaskar, Lakkakula V. K. S.
    Momin, Saimila
    Sujatha, Peela
    Reddy, Aramati B. M.
    Nagaraju, Ganji Purnachandra
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 127 : 50 - 55
  • [23] Characterization of the molecular mechanism of 5-lipoxygenase inhibition by 2-aminothiazoles
    Kretschmer, Simon B. M.
    Woltersdorf, Stefano
    Vogt, Dominik
    Lillich, Felix F.
    Ruehl, Michael
    Karas, Michael
    Maucher, Isabelle V.
    Roos, Jessica
    Haefner, Ann-Kathrin
    Kaiser, Astrid
    Wurglics, Mario
    Schubert-Zsilavecz, Manfred
    Angioni, Carlo
    Geisslinger, Gerd
    Stark, Holger
    Steinhilber, Dieter
    Hofmann, Bettina
    BIOCHEMICAL PHARMACOLOGY, 2017, 123 : 52 - 62
  • [24] Myxochelin-Inspired 5-Lipoxygenase Inhibitors: Synthesis and Biological Evaluation
    Schieferdecker, Sebastian
    Koenig, Stefanie
    Pace, Simona
    Werz, Oliver
    Nett, Markus
    CHEMMEDCHEM, 2017, 12 (01) : 23 - 27
  • [25] Impact of 5-Lipoxygenase Deficiency on Dopamine-Mediated Behavioral Responses
    Issy, Ana Carolina
    Pedrazzi, Joao Francisco
    Nascimento, Glauce Crivelaro
    Faccioli, Lucia Helena
    Del Bel, Elaine
    NEUROTOXICITY RESEARCH, 2024, 42 (05)
  • [26] The 5-lipoxygenase enzymatic pathway in the mouse brain:: Young versus old
    Chinnici, Cinzia M.
    Yao, Yuemang
    Pratico, Domenico
    NEUROBIOLOGY OF AGING, 2007, 28 (09) : 1457 - 1462
  • [28] Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma
    Bruno, Ferdinando
    Spaziano, Giuseppe
    Liparulo, Angela
    Roviezzo, Fiorentina
    Nabavi, Seyed Mohammed
    Sureda, Antoni
    Filosa, Rosanna
    D'Agostino, Bruno
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 153 : 65 - 72
  • [29] Suppression of 5-lipoxygenase activity by anionic cholesterol derivatives
    D. A. Aleksandrov
    G. F. Sud’ina
    Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2007, 1 (2) : 168 - 171
  • [30] Suppression of 5-Lipoxygenase Activity by Anionic Cholesterol Derivatives
    Aleksandrov, D. A.
    Sud'ina, G. F.
    BIOCHEMISTRY MOSCOW-SUPPLEMENT SERIES B-BIOMEDICAL CHEMISTRY, 2007, 1 (02) : 168 - 171